ArticlePediatric rheumatology online journal2025

Effect of additional intravenous immunoglobulin for infliximab-refractory Kawasaki disease: a cohort study.

Satoki Hatano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.